Aortic valve calcium load before TAVI: Is it important?

Similar documents
Aortic valve implantation using the femoral and apical access: a single center experience.

Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know?

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

Dr Winnie Sze-Wun Chan. Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong

Corrado Tamburino, MD, PhD

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

The Role of Imaging in Transcatheter Aortic Valve Implantation

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

TRANSCATHETER AORTIC VALVE REPLACEMENT

Jonathon Leipsic MD FRCPC FSCCT. Vice Chairman of Radiology University of British Columbia. Disclosures

Image Assistance in TAVI Why CT? Won-Jang Kim, MD, PhD Clinical Assistant Professor of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

TAVI EN INSUFICIENCIA AORTICA

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING

TAVR for low-risk patients in 2017: not so fast.

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

The learning curve associated with transapical aortic valve implantation

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Evolut R in bicuspid valve anatomies

TAVI Versus Suturless Valve In Intermediate Risk Patients

Keywords: Computed Tomography; Transesophageal Echocardiography; Transcatheter Aortic Valve Replacement

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Transcatheter Aortic Valve Replacement

Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

For Personal Use. Copyright HMP 2013

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

Optimal Imaging Technique Prior to TAVI -Echocardiography-

TAVI in Korea, How to Avoid Conduction

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Paravalvular Regurgitation is a Risk Factor Following TAVI

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

Technical consideration of aquiring and analyzing 3D TEE volume data sets (EchoPac ) Phasic changes of the aortic root throughout the cardiac cycle

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre

King s Research Portal

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

Transcatheter Aortic Valve Replacement with Evolut-R

7 th Conference of Transcatheter Heart Valve Therapies

PVL Assessment. Is paravalvular regurgitation after TAVR still an important consideration in 2018?

Impact of CoreValve size selection based on multi-slice computed tomography on paravalvular leak after transcatheter aortic valve implantation

Echo Assessment Pre-TAVI

Transcatheter aortic valve implantation and pre-procedural risk assesment

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Transcatheter Aortic Valve Implantation as a Bailout Procedure for Acute Aortic Valve Regurgitation During Endovascular Arch Repair

Dr.ssa Loredana Iannetta. Centro Cardiologico Monzino

Percutaneous transarterial aortic valve replacement. A practical tutorial for radiologists and how to approach special situations.

ECG Gated CT Aorta in Transcatheter Aortic Valve Implantation

Portico (St. Jude Medical Inc, St.

TAVI: Transapical Procedures

Percutaneous Therapy for Calcific Mitral Valve Disease

Aortic stenosis (AS) is the most common valve disease

Chapter. Eur Heart J. 2010;31:

First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always

PARTNER 2A & SAPIEN 3: TAVI for intermediate risk patients

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

Conflict of Interests

A review of the complications associated with Transcatheter Aortic Valve Implantation.

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

ΔΙΑΔΕΡΜΙΚΗ ΑΝΣΙΚΑΣΑΣΑΗ ΑΟΡΣΙΚΗ ΒΑΛΒΙΔΑ αντιμετώπιση επιπλοκών ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC IICE 2012

Complicanze durante TAVI. Brambilla Nedy IRCCS Policlinico San Donato

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Pacemaker After Transcatheter Aortic Valve Implantation: Where, When and How?

Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation

Learning experience with transapical aortic valve implantation the initial series from Leipzig

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

Cite this article as:

Transcatheter Aortic Valve Implantation Management of risks and complications

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation

When Does 3D Echo Make A Difference?

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

CoreValve in a Degenerative Surgical Valve

Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

Update on the CoreValve Experience

Current Evidence in TAVI patients using ACURATE and LOTUS valves

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and

Strokes After TAVR. Ioannis Iakovou, MD, PhD. Interventional Cardiology Onassis Cardiac Surgery Center

SURGICAL INTERVENTION IN AORTOPATHIES ZOHAIR ALHALEES, MD RIYADH, SAUDI ARABIA

Supplementary Appendix

2 Brigham and Women s Hospital, Boston, MA.

Minimally invasive aortic valve surgery: new solutions to old problems.

Maurizio D Amico M.D.

Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients?

Transapical Aortic Valve Implantation

Preprocedural evaluation for TAVR

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Feasibility of the Engager aortic transcatheter valve system using a flexible over-the-wire design

Transcription:

Research Highlight Aortic valve calcium load before TAVI: Is it important? Martin Haensig 1, Ardawan Julian Rastan 2 1 Department of Cardiac Surgery, Heart Center, University of Leipzig, Germany; 2 Department of Cardiac Surgery, Cardiovascular Center, Rotenburg/ Fulda, Germany Corresponding to: Ardawan Julian Rastan, MD, PhD. Department of Cardiac Surgery, Cardiovascular Center Rotenburg/Fulda, Heinz-Meise-Str. 100, 36199 Rotenburg a. d. Fulda, Germany. Email: a.rastan@hkz-rotenburg.de. Submitted May 05. Accepted for publication Jun 04, 2012. DOI: 10.3978/j.issn.2225-319X.2012.06.02 Cardiac surgeons were trained for decades to avoid paravalvular leakage as a major complication after aortic valve replacement. In contrast, with the widespread use of transcatheter aortic valve implantation techniques, paravalvular leaks are now considered as an acceptable outcome without serious consequences by some investigators. This might be true for trivial or mild paravalvular incompetence in patients within their last decade of life. However, with a more liberal TAVI indication, i.e. TAVI expansion to operable patients, even mild paravalvular leaks might be a matter of concern. For the first time, on the basis of a prospective, multicenter, randomized clinical trial, even mild paravalvular leaks have been associated with an increased long-term mortality (1). In addition, a recent study from the German transcatheter aortic valve registry has revealed that patients with paravalvular leaks are not just sicker in general, but are prone to a considerably higher in-hospital mortality (2). Thus, Aortic Valve Calcium Scoring (AVCS) pre- TAVI might be important with regard to outcome and paravalvular leaks. A recent study at the Heart Center Leipzig demonstrated a significant association between native aortic valve calcification and paravalvular leak in 120 patients [odds ratio (OR; per AVCS of 1,000), 11.38; 95% confidence interval (CI), 2.33-55.53; P=0.001, (3)]. Echocardiography (ECG)-gated cardiac computed tomography quantified the amount of calcification of the aortic valve leaflets using a scoring system analogous to the Agatston calcium scoring of coronary arteries [Aortic Valve Calcium Scoring (AVCS), Figure 1]. Paravalvular leaks were assessed and quantified intra-operatively by transoesophageal echocardiography (TEE) and root angiography. All valves were implanted successfully. The mean AVCS in patients without paravalvular leaks (n=66) was 2704±1510; with mild paravalvular leaks (n=31) was 3804±2739 (P=0.05); and with moderate paravalvular leaks (n=4) was 7387±1044 (P=0.002) (Table 1 and Figure 2). Consistent with this study, two further studies documented comparable results using the CoreValve ReValving system (4,5). Wood et al. (6) in contrast, did not find an association between paravalvular leaks and the degree of calcification, which was probably a result of the small study population. When analysing the localization of paravalvular leaks based on TEE, there was also a significant relation to the AVCS in each separate cusp or commissure (Table 2). A significant association was found for the right and left coronary cusp, and for the right-left and left-non-coronary commissure. This association, however, failed to reach statistical significance for the non-right-coronary commissure and the non-coronary cusp. One possible reason for this might be the intrinsic weakness and elasticity of the annulus in this area, leading to an anatomic predisposition to paravalvular leaks (7). There is well-accepted agreement, that valve calcification is a surrogate marker for the biological age and general morbidity of an individual patient. Temporary haemodialysis as well as ventilation time were both associated with a significantly higher AVCS (Table 3). More frequently increased AVCS values were observed in those with impaired respiratory function and renal disease, thus, suggesting that these patients are at a higher risk for postprocedural secondary complications and a longer in-hospital stay. Based on our experience, however, the AVCS was not a predictor of 30-day mortality, major cardiac events and stroke.

Annals of cardiothoracic surgery, Vol 1, No 2 July 2012 161 Figure 1 Aortic Valve Calcium Scoring (AVCS): Step by step. A: Place the crosshair on the aortic sinus in a transverse section. Switch to coronal view. B: Move the crosshair centre to the lowest part of the basal attachment of the NCL and rotate the crosshair until one plane reaches the corresponding part of the LCL. C: Switch to the sagittal view. Adapt the plane to the lowest part of the basal RCL attachment. Control the plane position by scrolling through the image stack. D: Switch to oblique transverse view to display the entire aortic annulus. Place the crosshair in the centre of the aortic annulus. E: Rotate the crosshair until the coronary ostia of LCA (1) and RCA (2) appear in the coronal or sagittal view. F: Select the entire aortic valve. Create a batch that reaches from the sinotubular junction to the basal attachments of the cusps. G: Create a batch for every cusp. Measure the AVCS for the entire valve and each separate cusp. H: Repeat step G for every commissure by rotating the selected area 60 clockwise. Measure the AVCS for each separate commissure Table 1 Preoperative transesophageal echocardiography results and mean Aortic Valve Calcium Score s (AVCS) for the aortic valve, cusps and commissures depending on the presence of a paravalvular leak AVCS No paravalvular leak* Paravalvular leak* P-value Aortic valve 2694±1528 4153±479 0.006 Right coronary cusp 811±542 1189±882 0.025 Left coronary cusp 919±644 1669±1514 0.001 Non-coronary cusp 1013±671 1281±750 0.053 Right-left-coronary commissure 782±554 1295±1071 0.010 Left-non-coronary commissure 1049±656 1589±1104 0.012 Non-right-coronary commissure 918±560 1258±941 0.110 Aortic Valve Calcium Score s (AVCS) for the aortic valve, cusps and commissures depending on the presence of a paravalvular leak. *: confirmed by intraoperative transesophageal echocardiography (TEE) and root angiography In contrast, in a previously published study (8) the degree of aortic valve calcification (calcium mass-score) was a significant predictor for 30-day MACE and for 1-year mortality. Patients with severe periprocedural complications (death, acute myocardial infarction and stroke) revealed significant more aortic valve calcium than patients without any complications. By selecting a calcium mass-score threshold of 750 the authors were able to identify more than 70% of patients who suffered subsequently from MACE or died within the first year. They concluded that such a parameter had enormous value in order to better select and risk-stratify candidates for TAVI.

162 Haensig and Rastan. AVCS before TAVI: Is it important? Aortic Valve Calcium Score 15.000 12.500 10.000 7.500 5.000 2.500 0 O O Figure 2 Mean AVCS for the entire aortic valve depending on the degree of a paravalvular leak. Significantly higher mean AVCS scores were found in patients with mild (1) and moderate (2) paravalvular leaks * P=0.00001 P=0.05 P=0.002 0(n=66) 1(n=31) 2(n=4) Degree of paravalvular leak Table 2 Association of Aortic Valve Calcium Score (AVCS), localization and degree of paravalvular leaks Impact of aortic valve calcification on paravalvular leaks Localization of paravalvular leak (TEE) R L N Calcium Score cusp R 5.64 P=0.018 1.84 P=0.17 1.03 P=0.87 (CT) L 1.94 P=0.16 5.43 P=0.020 1.61 P=0.20 N 1.85 P=0.17 3.59 P=0.058 1.35 P=0.56 RL LN NR commissure RL 4.88 P=0.027 2.70 P=0.10 1.02 P=0.90 LN 1.66 P=0.20 5.03 P=0.020 1.24 P=0.63 NR 1.27 P=0.61 2.25 P=0.13 1.37 P=0.24 Data are presented as odds ratio per AVCS of 1000 and corresponding P-values. *confirmed by intraoperative transesophageal echocardiography. Abbreviations: R, right coronary; L, left coronary; N, non-coronary; RL, right-left coronary; LN, left-non coronary; NR, non-right coronary Table 3 Impact of aortic valve calcification on outcome. CI OR p-value Paravalvular leak* [2.33;55.53] 11.38 0.001 Major cardiac event [0.68;1.25] 0.92 0.57 Stroke [0.41;1.96] 0.90 0.79 New pacemaker-implantation [0.85;1.89] 1.27 0.26 Temporary hemodialysis [0.96;14.53] 3.73 0.049 Median ventilation time 60 h [1.73;36.56] 7.94 0.005 Reintubation [0.86;9.82] 2.90 0.089 30-day mortality [0.84;1.32] 1.05 0.68 Data are presented as odds ratio per AVCS of 1,000, corresponding P-values and confidence intervalls (CI). *confirmed by postoperative transthoracic echocardiography before discharge Cardiac computed tomography (CT) is the gold standard imaging technique for assessing aortic valve calcification. Although, the cardiac CT-based AVCS has not been not cross-validated with the intraoperative transesophageal echocardiography (TEE), TEE assessment may add further information to better understand the morphology of the native calcified valve. A recent paper by Colli et al. (9) has examined the usefulness of an echocardiographic calcification score (ECS) to predict outcomes in 103 transapical TAVI patients. The ECS, as well as the aortic commissure calcification score alone, were predictive for the development of post- TAVI aortic regurgitation. The ECS was associated with the presence of moderate paravalvular aortic regurgitation (odds ratio 8.5; 95% confidence intervall, 1.2-58.9; P=0.0001) and overall moderate aortic regurgitation (odds ratio 3.6, 95% confidence intervall, 1.2-10.4; P=0.0006). The TEE gave detailed anatomic information of the calcification patterns of the aortic valve. The echocardiographic

Annals of cardiothoracic surgery, Vol 1, No 2 July 2012 163 Probability of paravalvular leak 1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 PROBIT (p) =4.3 * 10-4 -1.597 AVCS Cut-off Score (n = 120) Probability of a paravalvular leak 732.6 0.10 2145.3 0.25 3714.0 0.50 5282.6 0.75 6695.3 0.90 0 2.000 3714.0 6.000 8.000 10.000 Aortic Valve Calcium Score Figure 3 Probability of a paravalvular leak depending on the aortic valve calcium score calcification score (ECS) may be used to identify patients at high risk for the development of post-tavi AR and may therefore support decision making in the future. The main drawback of the study from Colli et al. (9) is the retrospective nature. Prospective randomized studies will be necessary to conclusively answer the question whether preoperative AVCS should be mandatory and helpful to predict AR after TAVI. On the other hand, a more calcified aortic root might offer superior grip and better seating in the native annulus during deployment. In a study by van Miegham et al. (10) patients with valve dislodgment had significantly less aortic root calcification using the Medtronic CoreValve TM system [median Agatston score 1,951 AU (IQR, 799-3,103) vs. 3,289 AU (IQR 2,097-4,481), P=0.016]. The incidence of valve dislodgment was three times higher when the Agatston calcification score was <2,359 AU by multi-slice computed tomography. Thus, in patients with a low AVCS the impact of aortic root calcium score on valve dislodgment seems robust and warrants further awareness among surgeons. In summary, the AVCS identifies patients at risk for a relevant paravalvular leak. The AVCS prior to TA- AVI might serve as an additional tool for surgeons to reconsider the TAVI indication and valve size to reduce the risk of paravalvular leaks (Figure 3). Clinically, we especially consider patients with a borderline risk score and a high calcium burden as non-tavi candidates (3). In self-expanding transcatheter heart valves which don't have the same radial forces as balloon-expandable valves, it may even play a major role, and even more impact on the postoperative result in terms of the persistence of paravalvular leaks and residual stenosis. If we can predict somehow whether these patients will have TAVI regurgitation or not, and this is one way to do it, it will in the future help us to define the best valve for a given patient and the best procedure. Acknowledgements Disclosure: The authors declare no conflict of interest. References 1. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-95. 2. Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 2011;97:899-906. 3. Haensig M, Lehmkuhl L, Rastan AJ, et al. Aortic valve calcium scoring is a predictor of significant paravalvular

164 Haensig and Rastan. AVCS before TAVI: Is it important? aortic insufficiency in transapical-aortic valve implantation. Eur J Cardiothorac Surg 2012;41:1234-41. 4. John D, Buellesfeld L, Yuecel S, et al. Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010;3:233-43. 5. Koos R, Mahnken AH, Dohmen G, et al. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 2010;150:142-5. 6. Wood DA, Tops LF, Mayo JR, et al. Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 2009;103:1295-301. 7. De Cicco G, Lorusso R, Colli A, et al. Aortic valve periprosthetic leakage: anatomic observations and surgical results. Ann Thorac Surg 2005;79:1480-5. 8. Leber AW, Kasel M, Ischinger T, et al. Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system. Int J Cardiol 2011 [Epub ahead of print]. 9. Colli A, D Amico R, Kempfert J, et al. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: Impact of aortic cusp calcification on postoperative aortic regurgitation. J Thorac Cardiovasc Surg 2011;142:1229-35. 10. Van Mieghem NM, Schultz CJ, van der Boon RM, et al. Incidence, timing, and predictors of valve dislodgment during TAVI with the medtronic corevalve system. Catheter Cardiovasc Interv 2011;79:726-32. Cite this article as: Haensig M, Rastan AJ. Aortic valve calcium load before tavi: Is it important? Ann Cardiothorac Surg 2012;1(2):160-164. DOI: 10.3978/j.issn.2225-319X.2012.06.02